Literature DB >> 24159160

Found: a cellular activating ligand for NKp44.

Sumati Rajagopalan1, Eric O Long.   

Abstract

In this issue of Blood, Baychelier et al identify a ligand for a major natural killer (NK) cell receptor that mediates natural cytotoxicity toward tumor cells, thus ending a search that lasted well over a decade.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24159160      PMCID： PMC3811168          DOI： 10.1182/blood-2013-09-523696

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  10 in total

1.  The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity.

Authors:  Claudia Cantoni; Marco Ponassi; Roberto Biassoni; Romana Conte; Andrea Spallarossa; Alessandro Moretta; Lorenzo Moretta; Martino Bolognesi; Domenico Bordo
Journal:  Structure       Date:  2003-06       Impact factor: 5.006

2.  Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.

Authors:  Francesco Marras; Elena Nicco; Federica Bozzano; Antonio Di Biagio; Chiara Dentone; Emanuele Pontali; Silvia Boni; Maurizio Setti; Giancarlo Orofino; Eugenio Mantia; Valentina Bartolacci; Francesca Bisio; Agostino Riva; Roberto Biassoni; Lorenzo Moretta; Andrea De Maria
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

3.  NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand.

Authors:  Vincent Vieillard; Jack L Strominger; Patrice Debré
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-26       Impact factor: 11.205

Review 4.  Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.

Authors:  Joachim Koch; Alexander Steinle; Carsten Watzl; Ofer Mandelboim
Journal:  Trends Immunol       Date:  2013-02-13       Impact factor: 16.687

5.  Identification of a cellular ligand for the natural cytotoxicity receptor NKp44.

Authors:  Florence Baychelier; Alexis Sennepin; Myriam Ermonval; Karim Dorgham; Patrice Debré; Vincent Vieillard
Journal:  Blood       Date:  2013-08-19       Impact factor: 22.113

6.  Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression and E2F1-responsive gene expression via association with host cell factor-1 (HCF-1).

Authors:  Peipei Zhou; Zhilong Wang; Xiujie Yuan; Cuihong Zhou; Lulu Liu; Xiaoling Wan; Feng Zhang; Xiaodan Ding; Chuangui Wang; Sidong Xiong; Zhen Wang; Jinduo Yuan; Qiang Li; Yan Zhang
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

7.  HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.

Authors:  Hugues Fausther-Bovendo; Vincent Vieillard; Sandrine Sagan; Georges Bismuth; Patrice Debré
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

Review 8.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Authors:  A Moretta; C Bottino; M Vitale; D Pende; C Cantoni; M C Mingari; R Biassoni; L Moretta
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

9.  Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication.

Authors:  Esther N M Nolte-'t Hoen; Catarina R Almeida; Nadia R Cohen; Shlomo Nedvetzki; Helen Yarwood; Daniel M Davis
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

10.  NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.

Authors:  M Vitale; C Bottino; S Sivori; L Sanseverino; R Castriconi; E Marcenaro; R Augugliaro; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307
  10 in total
  8 in total

Review 1.  MLL5 (KMT2E): structure, function, and clinical relevance.

Authors:  Xiaoming Zhang; Wisna Novera; Yan Zhang; Lih-Wen Deng
Journal:  Cell Mol Life Sci       Date:  2017-02-10       Impact factor: 9.261

Review 2.  Natural killer cell cytotoxicity and its regulation by inhibitory receptors.

Authors:  Santosh Kumar
Journal:  Immunology       Date:  2018-04-11       Impact factor: 7.397

3.  Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.

Authors:  Kiran Kundu; Susmita Ghosh; Rhitajit Sarkar; Avishay Edri; Michael Brusilovsky; Orly Gershoni-Yahalom; Rami Yossef; Avishai Shemesh; Jean-Charles Soria; Vladimir Lazar; Ben-Zion Joshua; Kerry S Campbell; Moshe Elkabets; Angel Porgador
Journal:  Cancer Immunol Res       Date:  2019-06-04       Impact factor: 11.151

4.  Survival in acute myeloid leukemia is associated with NKp44 splice variants.

Authors:  Avishai Shemesh; Michael Brusilovsky; Uzi Hadad; Omri Teltsh; Avishay Edri; Eitan Rubin; Kerry S Campbell; Benyamin Rosental; Angel Porgador
Journal:  Oncotarget       Date:  2016-05-31

5.  A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells.

Authors:  Kelly E Bowen; Stephen O Mathew; Kathleen Borgmann; Anuja Ghorpade; Porunelloor A Mathew
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

6.  NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint.

Authors:  Avishai Shemesh; Aleksandra Kugel; Naama Steiner; Michal Yezersky; Dan Tirosh; Avishay Edri; Omri Teltsh; Benyamin Rosental; Eyal Sheiner; Eitan Rubin; Kerry S Campbell; Angel Porgador
Journal:  Oncotarget       Date:  2016-10-25

Review 7.  Natural Killer Cells: Tumor Surveillance and Signaling.

Authors:  Lizeth G Meza Guzman; Narelle Keating; Sandra E Nicholson
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

Review 8.  Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications.

Authors:  Ioannis A Voutsadakis
Journal:  Cell Oncol (Dordr)       Date:  2018-02-22       Impact factor: 6.730
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.